Huons Meditech receives CE marking for Dermashine Pro
Huons Meditech receives CE marking for Dermashine Pro and Balance
The first digital infusion system from Korea to become CE MDR certified

The official ceremony for the presentation of the CE MDR certificate took place at Huons Meditech’s headquarter in Seongnam, South Korea on August 21
Huons Meditech, a medical device company of Huons Group, is making a move to enter the European market with its digital infusion system.
Huons Meditech (CEO Lee Jin-suk) announced on August 22 that it has received MDR (Medical Device Regulation) CE marking for its digital infusion system, ‘Dermashine Pro’ and ‘Dermashine Balance’.
This CE marking awarded to Huons Meditech, particularly under the recently enhanced MDR signifies that Dermashine Pro and Balance meet stringent European standards for safety and performance. This marks the first CE MDR certification for a digital infusion system from a company based in Korea.
Dermashine is Huons Meditech’s signature brand for skin aesthetic medical devices featuring precise drug infusion function and user-friendly design interface. The device is used to inject medications, such as Elravie Balance, a high-molecular-weight, high-concentration hyaluronic acid (HA) with skin-moisturizing effects, to the entire face.
The newly CE certified Dermashine Balance and Pro are next-generation products built on the first-generation Dermashine device, launched in 2011. They feature an infusion-sensing system, along with more refined drug volume and speed settings.
The company plans to officially enter the European market, leveraging the EU MDR CE mark for the Dermashine series. Huons Meditech plans to establish itself as a global brand, starting with its European launch and then expanding into Asia and the Americas.
CEO of Huons Meditech Lee Jin-suk said, “This CE MDR certification will serve as a significant milestone for Huons Meditech’s global expansion, including the European market. We will continue to drive innovation, develop superior products, and promote the excellence of K-Medical devices.”
Huons Meditech Expands into the Japanese Market with ‘Dermashine Duo_RF’
Huons Meditech Targets Southeast Asia Market at 'AMUSE 2026' in Indonesia
Huons Meditech Targets Latin American Market at 'Hospitalar 2026' Exhibition in Brazil
Huons Meditech Receives CE-MDR Approval for Aesthetic Drug Delivery System ‘Premium 9-Pin Needle’
Huons Meditech Strengthens Educational and Academic Marketing for Aesthetic Medical Device ‘Dermashine’
Humedix and Huons Meditech Sign Tripartite MOU with V&Co to Expand AI-powered Skin Diagnostics Business
Huons Meditech Showcased Innovative Medical Devices at ‘KIMES 2026’
Huons Group Chairman Yoon Sung-tae Attends in Inauguration of Endoscope Washer-Disinfector Production Line at India’s Vasu Group
Huons Meditech Showcases at ‘WHX Dubai 2026’
Huons Meditech Officially Launches ‘Dermashine Duo RF’, Combining Drug Delivery with Radiofrequency
Huons Meditech Participates in MEDICA 2025 in Germany
Huons Meditech Discusses Local Assembly Production Collaboration with India’s Vasu Group